OrthoPediatrics director granted 11,436 shares

Pelizzon David R reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Pelizzon David R reported acquisition or exercise transactions in this Form 4 filing.

OrthoPediatrics Corp director David R. Pelizzon received an award of 11,436 shares of common stock on June 9, 2026. The shares were granted at no cost as a stock award, increasing his direct holdings to 44,384 common shares, including 17,959 restricted stock awards.

The filing also reports 6,901,764 common shares held indirectly through Squadron Capital LLC. As President and a member of Squadron’s Managing Committee, Pelizzon may be deemed a beneficial owner, but he expressly disclaims beneficial ownership except for his pecuniary interest.

Insider Trade Summary

Grant/Award: 11,436 shares

Grant/Award 2 txns

Insider Pelizzon David R

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	11,436	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 44,384 shares (Direct); Common Stock — 6,901,764 shares (Indirect, See footnote)

Footnotes (2)

1. F1. Includes restricted stock awards totaling 17,959 shares.
2. F2. These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Key Figures

Stock award size: 11,436 shares Award grant price: $0.0000 per share Direct holdings after award: 44,384 shares +2 more

5 metrics

Stock award size 11,436 shares Common stock grant on June 9, 2026

Award grant price $0.0000 per share Price for 11,436-share stock award

Direct holdings after award 44,384 shares Common stock directly held following transaction

Restricted stock included 17,959 shares Restricted stock awards included in direct holdings

Indirect holdings via Squadron 6,901,764 shares Common stock held indirectly by Squadron Capital LLC

Key Terms

restricted stock awards, beneficial owner, pecuniary interest, Section 16, +1 more

5 terms

restricted stock awards financial

"Includes restricted stock awards totaling 17,959 shares."

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

beneficial owner financial

"the reporting person may be deemed to be the beneficial owner of these shares."

A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

pecuniary interest financial

"except to the extent of his pecuniary interest therein."

Section 16 regulatory

"shall not be deemed to be an admission of beneficial ownership for purposes of Section 16"

Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.

indirect ownership financial

"These shares are held by Squadron Capital LLC ("Squadron")."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did OrthoPediatrics (KIDS) director David R. Pelizzon report on this Form 4?

Director David R. Pelizzon reported receiving an award of 11,436 OrthoPediatrics common shares. The shares were granted at no cost, increasing his direct holdings to 44,384 shares, which include 17,959 restricted stock awards disclosed in the filing.

How many OrthoPediatrics (KIDS) shares does David R. Pelizzon hold directly after the award?

After the stock award, David R. Pelizzon directly holds 44,384 OrthoPediatrics common shares. This total includes 17,959 shares designated as restricted stock awards, reflecting his direct equity position reported as of the June 9, 2026 transaction date.

What is the size and nature of the stock award to the OrthoPediatrics (KIDS) director?

The OrthoPediatrics director received a stock award of 11,436 common shares. The shares were granted at a price of $0.0000 per share, indicating a compensation-related grant or award rather than an open-market purchase by the director.

What indirect OrthoPediatrics (KIDS) holdings related to Squadron Capital LLC are disclosed?

The filing reports 6,901,764 OrthoPediatrics common shares held indirectly by Squadron Capital LLC. As Squadron’s President and a Managing Committee member, Pelizzon may be deemed a beneficial owner but expressly disclaims beneficial ownership except for his pecuniary interest.

Does David R. Pelizzon claim full beneficial ownership of the Squadron Capital OrthoPediatrics (KIDS) shares?

No. Although Pelizzon’s role at Squadron Capital means he may be deemed a beneficial owner of 6,901,764 shares, he expressly disclaims beneficial ownership of those shares, except to the extent of his pecuniary interest, as stated in the footnote.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/10/2026 - 09:54 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pelizzon David R

(Last) (First) (Middle)

C/O SQUADRON CAPITAL LLC

18 HARTFORD AVE., PO BOX 223

(Street)

GRANBY CONNECTICUT 06035

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ORTHOPEDIATRICS CORP [ KIDS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/09/2026		A		11,436	A	$0	44,384(1)	D
Common Stock								6,901,764	I	See footnote(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes restricted stock awards totaling 17,959 shares.

2. These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Remarks:

	/s/ Daniel J. Gerritzen, Attorney-in-Fact	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)